Translational geroscience bridges basic aging research with clinical application. It focuses on converting discoveries about aging mechanisms into interventions that improve healthspan and delay disease. Translational geroscience emphasizes biomarkers, intervention timing, and real-world outcomes. By targeting aging biology itself, this field aims to prevent multiple age-related conditions simultaneously. Translational geroscience integrates molecular research, clinical trials, and population health strategies. Understanding this discipline is essential for moving aging interventions from laboratory studies to clinical practice and public health implementation.
Title : Change your genes – Change your life: Epigenetics of longevity
Kenneth R Pelletier, University of California School of Medicine, United States
Title : Improving mobility and health in over 45,000 humans using nanomedicine
Thomas J Webster, Brown University, United States
Title : An introduction to alchemical facial acupuncture: Sparking the shen
Mary Elizabeth Wakefield, Chi-Akra Center for Ageless Aging, United States
Title : Decoding the secret of longevity through big data: Noncoding RNAs—not proteins—drive animal lifespan evolution
Anyou Wang, DIFIBER LLC, United States
Title : Aspirin guided by coronary artery calcium scoring for primary prevention in persons with subclinical coronary heart disease
Arthur J Siegel, McLean Hospital, United States
Title : When BMI misleads: Integrating body composition, biomarkers, and personalized interventions for cardiometabolic healthspan in aging Asian and European cohorts
Narendra Kumar, HeartbeatsZ Academy, United Kingdom